The effect of growth hormone (GH) on subclinical disease activity in a
15-year-old boy with previously quiescent lupus nephritis and chronic
renal failure is described. Institution of supraphysiological doses o
f GH resulted in a rise in erythrocyte sedimentation rate, decrease in
serum complement, rise in anti-DNA antibody titers, and increase in T
-cell activation markers, all of which improved following cessation of
GH treatment.